var CasaleArgs = new Object (); CasaleArgs.version = 2; CasaleArgs.adUnits = "4 "; CasaleArgs.casaleID = 129019;

Disfunción sexual femenina (DSF) se debe en realidad un gran avance en términos de tratamiento, pero TDSH (deseo sexual hipoactivo), una de las condiciones bajo el término genérico de FSD, tendrán otro tratamiento para los pacientes en forma de LibiGel, la hormona gel.

El tratamiento tópico se encuentra en ensayos clínicos fase tardía y se dice que es el tratamiento siguiente avance en el mercado. FSD is as ever a controversial topic that is always debated in the media by everyone else but the sufferers and by very few physicians. Men and women who know nothing of the experience of this kind of sexual dysfunction and who own no professional medical qualifications like to run around making bias documentaries and framing the pharmaceutical industries as greedy and as having, themselves, created the condition of FSD.

There are of course no grounds for this but a probable reason for it might be that there are many different aspects involved with FSD thus making the condition difficult to understand. FSD is an umbrella term for many different problems women have with sexual dysfunction. Some women simply do not feel the desire to have sex anymore after menopause or in cases where they have had a surgical menopause, this is HSDD. This is why we apply testosterone topically or use patches.

Other problems women face includes a dryness of the vagina and pain during intercourse along with this dryness or as a result of it. Other problems include issues surrounding orgasm. Many women have this problem. Parte de la evidencia sugiere que este es el caso por razones psicológicas y otros médicos creen que la incapacidad para el orgasmo podría tener que ver con problemas relacionados con el flujo de sangre hacia el clítoris.

Es risible que los cineastas y periodistas que piensan que saben mejor que la FSD que sufren las mujeres se pueden dar a conocer su trabajo y sus opiniones con tanta confianza. Con 25 millones de mujeres en la menopausia quirúrgica EE.UU. aproximadamente el problema de la HSDD es innegable. The other argument of course is that it is men and the pharmaceutical companies who are making an issue out of a waning sense of sexual desire and not the women. This is not true. A majority of women might be a little shy about talking to their GPS about their sexual problems since female sexuality has always been a more taboo topic for women than it has been for men.

Related

No hay comentarios

Aún no hay comentarios.

Canal RSS de los comentarios de la entrada.

Disculpa, los comentarios están cerrados.

Powered by Yahoo! Answers